-transparent.png){kind=logo}
Sixteen healthy male volunteers participated in a randomized, balanced, three-way crossover study comparing the pharmacokinetics of cefmetazole, cefoxitin, and cefmetazole with probenecid pretreatment. Single 2-g doses of cefmetazole sodium and cefoxitin sodium were given intravenously as a 5-min infusion. Concentrations of cefmetazole and cefoxitin were determined by using a specific semiautomated high-performance liquid chromatographic method. Concentration-time profiles of cefmetazole and cefoxitin declined in a biexponential manner from peak levels. Compared with cefoxitin, cefmetazole had a significantly (P less than 0.05) higher mean (+/- standard error of the mean) peak concentration in serum (290 +/- 11 versus 244 +/- 10 micrograms/ml), a longer terminal disposition half-life (1.50 +/- 0.14 versus 0.81 +/- 0.04 h), lower systemic clearance (111.7 +/- 4.7 versus 279 +/- 12 ml/min) and renal clearance (78.7 +/- 4.3 versus 221 +/- 14 ml/min) of intact drug, and a slightly smaller steady-state volume of distribution (10.3 +/- 0.21 versus 12.8 +/- 0.48 liters). Mean recoveries of cefmetazole and cefoxitin in urine were approximately 71 and 77%, respectively. Pretreatment of volunteers with probenecid (1 g orally) significantly (P less than 0.05) increased concentrations of cefmetazole in serum 1 h after drug administration without significantly increasing maximum concentrations in serum. Mean areas under the concentration-time curve (466 +/- 27 versus 295 +/- 13 micrograms.h/ml) and terminal disposition half-lives (2.27 +/- 0.13 versus 1.50 +/- 0.14 h) of cefmetazole increased. Systemic clearance (72.1 +/- 4.0 versus 111.7 +/- 4.7 ml/min) and renal clearance (47.4 +/- 4.0 versus 78.7 +/- 4.3 ml/min) of intact antibiotic decreased. Mean recoveries (65.9 +/- 3.7 versus 71.0 +/- 3.2%) of intact cefmetazole in urine were not significantly (P > 0.05) different. Elimination of cefmetazole in urine was also significantly prolonged by probenecid, with substantial concentrations of cefmetazole (>/= 20 micrograms/ml) found in the 12- to 24-h urine collection for 14 to 16 volunteers. The results show that cefmetazole remains at clinically relevant concentrations (1 to 2 micrograms/ml) approximately twice as long as cefoxitin, that serum cefmetazole can be maintained longer at clinically significant concentrations with preadministration of probenecid, and that cefmetazole is partially eliminated by renal tubule secretion.
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
May 1980,
Antimicrobial agents and chemotherapy,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
October 1985,
Antimicrobial agents and chemotherapy,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
November 1981,
The Journal of antimicrobial chemotherapy,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
May 1983,
Praxis und Klinik der Pneumologie,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
May 1982,
Antimicrobial agents and chemotherapy,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
June 1981,
British journal of clinical pharmacology,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
January 1978,
Anesthesia and analgesia,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
August 1984,
Antimicrobial agents and chemotherapy,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
January 1979,
Scandinavian journal of infectious diseases,
H Ko, and
K S Cathcart, and
D L Griffith, and
G R Peters, and
W J Adams
August 1980,
Diabetologia,
